Evidence map›Paper›PMID 42418388›Full record

ArticleBlood advances2026

TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.

Benjamin Podvin, Holly Lee, Rémi Tilmont, Gauthier Decool, Doriane Cavalieri, Hélène Demarquette, Nicolas Gower, Morgane Nudel, Emmanuelle Bourgeois, Daniela Robu and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Benjamin PodvinLaboratory of Hematology, Centre Hospitalier Universitaire de Lille, Lille, France.ORCID 0000-0002-0616-8694
Holly LeeHematology Department, Arthur Child Comprehensive Cancer Center, University of Calgary, Calgary, AB, Canada.
Rémi TilmontTumor Persistence and Immune Response in Hematological Malignancies Laboratory, Interdisciplinary Cancer Research Center of Lille, University of Lille, INSERM U1366, Lille, France.
Gauthier DecoolLaboratory of Hematology, Centre Hospitalier Universitaire de Lille, Lille, France.
Doriane CavalieriHematology Department, Lille University Hospital, Lille, France.ORCID 0000-0002-4836-7237
Hélène DemarquetteHematology Department, Dunkerque Hospital, Dunkerque, France.
Nicolas GowerHematology Department, Lille University Hospital, Lille, France.
Morgane NudelHematology Department, Lille University Hospital, Lille, France.
Emmanuelle BourgeoisHematology Department, Groupe Hospitalier de l'Institut Catholique Lillois, Lille, France.
Daniela RobuHematology Department, Lens Hospital, Lens, France.ORCID 0009-0007-3893-0464
Sabine TricotDepartment of Hematology, Valenciennes Hospital, Valenciennes, France.
Inès AribHematology Department, Lille University Hospital, Lille, France.
Victoria CacheuxHematology Department, Lille University Hospital, Lille, France.
Aurélie Caillault-VenetLaboratory of Hematology, Centre Hospitalier Universitaire de Lille, Lille, France.
Claude PreudhommeLaboratory of Hematology, Centre Hospitalier Universitaire de Lille, Lille, France.ORCID 0000-0002-1267-9546
Nicolas DuployezLaboratory of Hematology, Centre Hospitalier Universitaire de Lille, Lille, France.ORCID 0000-0002-3927-1022
Thierry FaconHematology Department, Lille University Hospital, Lille, France.
Paola NeriHematology Department, Arthur Child Comprehensive Cancer Center, University of Calgary, Calgary, AB, Canada.
Nizar BahlisHematology Department, Arthur Child Comprehensive Cancer Center, University of Calgary, Calgary, AB, Canada.
Salomon ManierTumor Persistence and Immune Response in Hematological Malignancies Laboratory, Interdisciplinary Cancer Research Center of Lille, University of Lille, INSERM U1366, Lille, France.ORCID 0000-0001-7653-711X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42418388
PMCPMC13558235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.